Risk-Factor Based Lead Screening and Correlation with Blood Lead Levels in Pregnancy
-
2022/01/01
-
Details
-
Personal Author:Erlinger AL ; Hacker MR ; Hart JM ; Hauptman M ; Johnson KM ; Karumanchi SA ; O'Brien K ; Salahuddin S ; Specht AJ ; Woolf AD ; Wylie BJ
-
Description:Objectives: Lead exposure has devastating neurologic consequences for children and may begin in utero. The American College of Obstetricians and Gynecologists recommends prenatal lead screening using a risk factor-based approach rather than universal blood testing. The clinical utility of this approach has not been studied. We evaluated a risk-factor based questionnaire to detect elevated blood lead levels in pregnancy. Methods: We performed a secondary analysis of a cohort of parturients enrolled to evaluate the association of lead with hypertensive disorders of pregnancy. We included participants in this analysis if they had a singleton pregnancy ≥ 34 weeks' gestation with blood lead levels recorded. Participants completed a lead risk factor survey modified for pregnancy. We defined elevated blood lead as ≥ 2 µg/dL, as this was the clinically reportable level. Results: Of 102 participants enrolled in the cohort, 92 had blood lead measured as part of the study. The vast majority (78%) had 1 or more risk factor for elevated lead using the questionnaire yet none had clinical blood lead testing during routine visits. Only two participants (2.2%) had elevated blood lead levels. The questionnaire had high sensitivity but poor specificity for predicting detectable lead levels (sensitivity 100%, specificity 22%). Conclusions for practice: Prenatal risk-factor based lead screening appears underutilized in practice and does not adequately discriminate between those with and without elevated blood levels. Given the complexity of the risk factor-based approach and underutilization, the benefit and cost-effectiveness of universal lead testing should be further explored. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1092-7875
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:185-192
-
Volume:26
-
Issue:1
-
NIOSHTIC Number:nn:20064357
-
Citation:Matern Child Health J 2022 Jan; 26(1):185-192
-
Contact Point Address:Katherine M. Johnson, Department of Obstetrics and Gynecology, University of Massachusetts Medical School/University of Massachusetts Memorial Medical Center, 119 Belmont Street, Worcester, MA 01605, USA
-
Email:katherine.johnson@umassmemorial.org
-
CAS Registry Number:
-
Federal Fiscal Year:2022
-
Performing Organization:Harvard School of Public Health, Boston, Massachusetts
-
Peer Reviewed:True
-
Start Date:20190901
-
Source Full Name:Maternal and Child Health Journal
-
End Date:20220831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:954a6f36248a5846f3078e0d8cdcc81a8ef8b651b07485ffbe0870522117ab4ff89fdabdc6845df056f19187c5b600c8327c3eb477cb613e3a79af6eb5b220d7
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like